The Patent Finder

Terms ending in 2038

Array Biopharma Inc.

Every in-force patent on Array Biopharma Inc.'s record whose computed term ends in 2038, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 11,168,090SUBSTITUTED PYRAZOLO[1,5-a]PYRAZINES AS RET KINASE INHIBITORS
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 11,851,434Substituted Pyrazolo[1,5-a]pyrazine Compounds as Ret Kinase Inhibitors
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 11,648,243Substituted Pyrazolo[1,5-a]pyridine Compounds as Ret Kinase Inhibitors
In force
 · High confidence
Array Biopharma, Inc.In forceHigh confidence
US 10,584,124Crystalline Forms
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
US 10,745,419Process for the Preparation of 6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
In force
 · High confidence
Loxo Oncology, Inc.In forceHigh confidence
US 11,098,064Process for the Preparation of 6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
In force
 · High confidence
Loxo Oncology, Inc.In forceHigh confidence
US 11,807,651Process for the Preparation of 6-(2-Hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile
In force
 · High confidence
Loxo Oncology, Inc.In forceHigh confidence
US 11,247,990Bicyclic Fused Pyridine Compounds as Inhibitors of Tam Kinases
In force
 · High confidence
Array Biopharma Inc.In forceHigh confidence
8 of 8 patents shown. Soonest term end first, then patent number.
5 of these are in force and held by Array Biopharma Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited